Kcentra 1,000 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCYX6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,593
Award facts
- Contract value 100% obligated
- $20,592.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,592.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The award was issued on November 24, 2025, with an ultimate completion date of December 16, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order falls under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
The PPV-G GEN V represents the Defense Logistics Agency's broader $30.3 billion acquisition strategy to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. As a critical supplier within this framework, DMS Pharmaceutical Group has demonstrated substantial performance across numerous delivery orders encompassing specialty pharmaceuticals, vaccines, biologics, and routine medications. Kcentra, a prothrombin complex concentrate used in emergency medical situations, aligns with the contractor's established portfolio of critical therapeutic agents supporting military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCYX6?
SPE2DR26FCYX6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FCYX6 worth?
The government has obligated $20,593 on SPE2DR26FCYX6.
Is contract SPE2DR26FCYX6 an order under another contract?
Yes. SPE2DR26FCYX6 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYX6 competed?
The extent of competition for SPE2DR26FCYX6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award